Patents-Review.com
ClassID:

20971 ⎘

A61K38/2053 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-8

Recent Application in this class:
#1
20250367221
2025-12-04

METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY

 #2
20250222035
2025-07-10

PROCESSES FOR MAKING AND USING A MESENCHYME STEM CELL SECRETOME FOR LIMBAL STEM CELL DEFICIENCY (LSCD) TREATMENT

 #3
20250177455
2025-06-05

NOVEL THERAPEUTIC COMPRISING A SECRETOME FROM MESENCHYMAL STEM CELLS OF UMBILICORD TISSUE OR WHARTON'S JELLY

 #4
20240299448
2024-09-12

METHODS FOR PREVENTING AND TREATING CHRONIC PAIN

 #5
20240033297
2024-02-01

PROCESSES FOR MAKING AND USING A MESENCHYMAL STEM CELL DERIVED SECRETOME

 #6
20240024371
2024-01-25

TREATING DIABETES

 #7
20240012011
2024-01-11

METHODS AND ASSAYS FOR SECRETOME ACTIVITY ANALYSIS

 #8
20230321190
2023-10-12

PHARMACEUTICAL AND COSMETIC COMPOSITIONS COMPRISING SECRETOMES

 #9
20230158075
2023-05-25

METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY

 #10
20220249613
2022-08-11

CELL CULTURE FOR TREATING DISEASE IN THE LOWER LIMBS

 #11
20220249575
2022-08-11

FORMULATION AND TREATMENT FOR OPHTHALMIC DISORDERS

 #12
20210386827
2021-12-16

CELL-FREE COMPOSITIONS AND METHODS FOR RESTORATION OR ENHANCEMENT OF TISSUE FUNCTION

 #13
20210353683
2021-11-18

ADDITIVE FOR MEDIUM FOR PROMOTING PRODUCTION OF PARACRINE FACTOR

 #14
20210187034
2021-06-24

Processes for making and using a mesenchymal stem cell derived secretome

 #15
20210106651
2021-04-15

BIO-MIMETIC FORMULATION

 #16
20210052656
2021-02-25

Processes for making and using a mesenchymal stem cell derived secretome

 #17
20210046161
2021-02-18

SKIN OINTMENT FOR TREATING LABIA MINORA SKIN

 #18
20200330557
2020-10-22

USES OF PD-1/PD-L1 INHIBITORS AND/OR CTLA-4 INHIBITORS WITH A BIOLOGIC CONTAINING MULTIPLE CYTOKINE COMPONENTS TO TREAT CANCER

 #19
20200164049
2020-05-28

TREATMENT OF HUMAN METAPNEUMOVIRUS

 #20
20200078444
2020-03-12

Compositions and methods using IL-8 for improving health of mammals

 #21
20200046803
2020-02-13

Compositions and methods using IL-8 to improve milk production and reproductive health in mammals

 #22
20190374617
2019-12-12

Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides

 #23
20190350890
2019-11-21

COMPOSITION FOR PREVENTING OR TREATING HEPATITIS CONTAINING MONOACETYL DIACYLGLYCEROL COMPOUND

 #24
20190298763
2019-10-03

USE OF DNA NETOSIS TO DELIVER TRAIL FOR CANCER THERAPY

 #25
20190224277
2019-07-25

BIO-MIMETIC FORMULATION

 #26
20190192577
2019-06-27

Postpartum cells derived from placental tissue, and methods of making and using the same

 #27
20190022185
2019-01-24

Cytokine receptor peptides, compositions thereof and methods thereof

 #28
20180369283
2018-12-27

Methods of conditioning patients for T cell therapy

 #29
20180338999
2018-11-29

Soft tissue repair and regeneration using postpartum-derived cells and cell products

 #30
20180028615
2018-02-01

Compositions and methods using IL-8 to improve milk production and reproductive health in mammals

 #31
20170368101
2017-12-28

Methods of conditioning patients for T cell therapy

 #32
20170326183
2017-11-16

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

 #33
20170246216
2017-08-31

Human amniotic fluid preparation having long-term stability

 #34
20170239299
2017-08-24

Postpartum cells derived from placental tissue, and methods of making and using the same

 #35
20170216366
2017-08-03

Conditioned medium obtained from placental mesenchymal stem cells and use thereof in the therapeutic treatment of preeclampsia

 #36
20170182100
2017-06-29

Conditioned medium of liver progenitor cells

 #37
20170166864
2017-06-15

Postpartum cells derived from placental tissue, and methods of making and using the same

 #38
20170166863
2017-06-15

Postpartum cells derived from placental tissue, and methods of making and using the same

 #39
20170143770
2017-05-25

Soft tissue repair and regeneration using postpartum-derived cells and cell products

 #40
20170087213
2017-03-30

Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors

 #41
20170000853
2017-01-05

WOUND HEALING COMPOSITION

 #42
20160361388
2016-12-15

METHOD AND COMPOSITION FOR THE TREATMENT OF MODERATE TO SEVERE KERATOCONJUNCTIVITIS SICCA

 #43
20160346355
2016-12-01

Cytokine receptor peptides, compositions thereof and methods thereof

 #44
20160324924
2016-11-10

COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX

 #45
20160324898
2016-11-10

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

 #46
20160303198
2016-10-20

Method of immunotherapy for treatment of human papillomavirus infection

 #47
20160279191
2016-09-29

Antibiotic composition comprising a chemotactic agent and a nutrient dispersion

 #48
20160106858
2016-04-21

Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides

 #49
20160089420
2016-03-31

Activated leukocyte conditioned supernatant and uses for wound healing

 #50
20150283073
2015-10-08

Cancer cell trap

 #51
20150250823
2015-09-10

Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour

 #52
20150238528
2015-08-27

Formulations involving solvent/detergent-treated plasma (S/D plasma) and uses thereof

 #53
20150190429
2015-07-09

Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions

 #54
20150125422
2015-05-07

Hepatitis C virus inhibitors

 #55
20150064133
2015-03-05

Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same

 #56
20150023911
2015-01-22

DEVICE-BASED METHODS FOR LOCALIZED DELIVERY OF CELL-FREE CARRIERS WITH STRESS-INDUCED CELLULAR FACTORS

 #57
20150023908
2015-01-22

Skin cream

 #58
20150010497
2015-01-08

Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors

 #59
20140378371
2014-12-25

Cytokine receptor peptides, compositions thereof and methods thereof

 #60
20140363394
2014-12-11

Formulation having mobilizing activity

 #61
20140348783
2014-11-27

Vaccine immunotherapy for treating cervical cancer in immune suppressed patients

 #62
20140348782
2014-11-27

Vaccine immunotherapy for treating lymphoma in immune suppressed patients

 #63
20140348780
2014-11-27

Antibiotic composition comprising a chemotactic agent and a nutrient dispersion

 #64
20140030217
2014-01-30

Vaccine immunotherapy

 #65
20140010780
2014-01-09

Vaccine immunotherapy for treating hepatocellular cancer in immune suppressed patients

 #66
20140010779
2014-01-09

VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

 #67
20130344119
2013-12-26

Method for inducing in vivo migration of stem cell

 #68
20130243723
2013-09-19

Vaccine immunotherapy

 #69
20130224148
2013-08-29

Activated leukocyte conditioned supernatant and uses for wound healing

 #70
20130115190
2013-05-09

Hepatitis C virus inhibitors

 #71
20130022585
2013-01-24

Regeneration and repair of neural tissue using postpartum-derived cells

 #72
20120244117
2012-09-27

Method of immunotherapy for treament of human papillomavirus infection

 #73
20120225029
2012-09-06

Skin cream

 #74
20120207705
2012-08-16

Stem Cell Conditioned Medium Compositions

 #75
20120177660
2012-07-12

BIOMARKERS AND THERAPEUTIC TARGETS FOR TYPE 1 DIABETES

 #76
20120070405
2012-03-22

Uses of modified ELR-CXC chemokine G31P to treat cancer

 #77
20120064035
2012-03-15

Vaccine immunotherapy

 #78
20110300097
2011-12-08

Method And Composition For The Treatment Of Moderate To Severe Keratoconjunctivitis Sicca

 #79
20110236431
2011-09-29

TREATMENT OF ACUTE MYOCARDIAL INFARCTION (AMI) USING ENCAPSULATED CELLS ENCODING AND SECRETING GLP-1 PEPTIDES OR ANALOGS THEREOF

 #80
20110229433
2011-09-22

USE OF MODIFIED INTERLEUKIN-8 PROTEINS FOR TREATING REPERFUSION INJURY OR TRANSPLANT REJECTION

 #81
20110129439
2011-06-02

Conditioned medium of liver progenitor cells

 #82
20110110884
2011-05-12

IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

 #83
20110076249
2011-03-31

IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

 #84
20110046069
2011-02-24

Uses of modified ELR-CXC chemokine G31P

 #85
20110044937
2011-02-24

STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY

 #86
20110038921
2011-02-17

METHODS AND COMPOSITIONS FOR TEMPORAL RELEASE OF AGENTS FROM A BIODEGRADABLE SCAFFOLD

 #87
20110021422
2011-01-27

Method and compositions for prevention and treatment of diabetic and aged skin

 #88
20110002883
2011-01-06

THERAPEUTIC PREPARATIONS CONTAINING WHARTON'S JELLY

 #89
20100310469
2010-12-09

VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

 #90
20100260843
2010-10-14

Regeneration and repair of neural tissue using postpartum-derived cells

 #91
20100254938
2010-10-07

Formulation having mobilising activity

 #92
20100210013
2010-08-19

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

 #93
20100178355
2010-07-15

METHOD FOR IN SITU SOLIDIFICATION OF BLOOD-POLYMER COMPOSITIONS FOR REGENERATIVE MEDICINE AND CARTILAGE REPAIR APPLICATIONS

 #94
20100047205
2010-02-25

Vaccine immunotherapy

 #95
20100034771
2010-02-11

Cytokine receptor peptides, compositions thereof and methods thereof

 #96
20090304650
2009-12-10

Repair of the Bone Marrow Vasculature

 #97
20090221497
2009-09-03

Immunodynamic complexes and methods for using and preparing such complexes

 #98
20090180982
2009-07-16

VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

 #99
20080317816
2008-12-25

Porous objects having immobilized encapsulated biomolecules

 #100
20080274098
2008-11-06

Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease

 #101
20070172467
2007-07-26

Treatment of tumor with dnazyme directed to peroxiredoxin

 #102
20070059288
2007-03-15

Treatment for heart disease

 #103
20070041956
2007-02-22

Vaccine immunotherapy for immune suppressed patients

 #104
20070036767
2007-02-15

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

 #105
20070031372
2007-02-08

Vaccine immunotherapy for immune suppressed patients

 #106
20070025958
2007-02-01

Vaccine immunotherapy

 #107
20070014771
2007-01-18

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

 #108
20070009494
2007-01-11

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

 #109
20060239965
2006-10-26

Extracellular matrix binding chimeric proteins and methods of use thereof

 #110
20060234376
2006-10-19

Repair and regeneration of ocular tissue using postpartum-derived cells

 #111
20060233748
2006-10-19

Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease

 #112
20060194242
2006-08-31

Immunotherapy for immune suppressed patients

 #113
20060188983
2006-08-24

Postpartum-derived cells for use in treatment of disease of the heart and circulatory system

 #114
20060154367
2006-07-13

Cartilage and bone repair and regeneration using postpartum-derived cells

 #115
20060154366
2006-07-13

Method of differentiating umbilical cord tissue into a chondrogenic phenotype

 #116
20060153818
2006-07-13

Cartilage and bone repair and regeneration using postpartum-derived cells

 #117
20060153817
2006-07-13

Cartilage and bone repair and regeneration using postpartum-derived cells

 #118
20060153816
2006-07-13

Soft tissue repair and regeneration using postpartum-derived cells and cell products

 #119
20060147416
2006-07-06

Method for the treatment of myelodysplastic syndromes using cyclopropanecarboxylic acid {2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-OXO-2,3-dihydro-1 H-isoindol-4-yl}-amide

 #120
20050265963
2005-12-01

Immunodynamic complexes and methods for using and preparing such complexes

 #121
20050249699
2005-11-10

Immunodynamic complexes and methods for using and preparing such complexes

 #122
20050233992
2005-10-20

Method of inhibiting collagen formation by VDUP1 inhibition

 #123
20050152874
2005-07-14

Vaccine immunotherapy for immune suppressed patients

 #124
20050089535
2005-04-28

Delivery of biologically active agents

 #125
20050058631
2005-03-17

Postpartum cells derived from placental tissue, and methods of making and using the same

 #126
20050058630
2005-03-17

Postpartum-derived cells for use in treatment of disease of the heart and circulatory system

 #127
20050058629
2005-03-17

Soft tissue repair and regeneration using postpartum-derived cells

 #128
20050054098
2005-03-10

Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same

 #129
20050037491
2005-02-17

Treatment of retinitis pigmentosa with human umbilical cord cells

 #130
20050032209
2005-02-10

Regeneration and repair of neural tissue using postpartum-derived cells

 #131
20050019865
2005-01-27

Cartilage and bone repair and regeneration using postpartum-derived cells

 #132
16785470
2020-09-01

Processes for making and using a mesenchymal stem cell derived secretome